Tirilazad Mesylate Improves Survival of Rat and Human Embryonic Mesencephalic Neuronsin Vitro
- 31 October 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 147 (2) , 498-502
- https://doi.org/10.1006/exnr.1997.6594
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Lazaroid Treatment Prevents Death of Cultured Rat Embryonic Mesencephalic Neurons Following Glutathione DepletionJournal of Neurochemistry, 2002
- The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4°C and subsequently used for cultures or intracerebral transplantationBrain Research Bulletin, 1996
- Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's DiseaseNew England Journal of Medicine, 1995
- Lazaroids improve the survival of cultured rat embryonic mesencephalic neuronesNeuroReport, 1994
- Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and functionBrain Research, 1994
- Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose AdministrationThe Journal of Clinical Pharmacology, 1993
- Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system traumaJournal of Medicinal Chemistry, 1990
- The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemiaDrugs of the Future, 1989
- Cryopreservation of primary neurons for tissue cultureBrain Research, 1986
- Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survivalBrain Research, 1985